Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Official title:
Pharmacokinetics of Sildenafil in Premature Infants
The purpose of this study is to learn more about the safety and dosing of sildenafil in infants.
Pharmacokinetics and safety of sildenafil will be studied in preterm infants who are receiving sildenafil per standard of care or 1 dose prescribed for the study. ;
Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04328636 -
Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn
|
Phase 1/Phase 2 | |
Recruiting |
NCT02380040 -
Plethismographic Perfusion Index in Neonates
|
N/A | |
Withdrawn |
NCT01360671 -
IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn
|
Phase 2 | |
Terminated |
NCT02261883 -
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
|
Phase 2 | |
Completed |
NCT04841070 -
NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn
|
N/A | |
Recruiting |
NCT05741229 -
The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns
|
N/A | |
Recruiting |
NCT00710177 -
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
|
||
Completed |
NCT02940327 -
Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN
|
||
Terminated |
NCT01389856 -
Persistent Pulmonary Hypertension of the Newborn
|
Phase 3 | |
Terminated |
NCT01069861 -
Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)
|
Phase 2 | |
Active, not recruiting |
NCT02951130 -
Milrinone in Congenital Diaphragmatic Hernia
|
Phase 2 | |
Enrolling by invitation |
NCT04938167 -
Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension
|
N/A | |
Not yet recruiting |
NCT04379180 -
Population Pharmacokinetics and Dosage Individualization of Oral Pulmonary Vasodilators in PPHN
|